Codeine not to be used in children below 12 years for cough and cold

The Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) has agreed by consensus new measures to minimise the risk of serious side effects

CMDh has agreed by consensus new measures to minimise the risk of serious side effects, including breathing problems, with codeine-containing medicines when used for cough and cold in children. As a result of these new measures:

  • Use of codeine for cough and cold is now contraindicated in children below 12 years. This means it must not be used in this patient group.
  • Use of codeine for cough and cold is not recommended in children and adolescents between 12 and 18 years who have breathing problems.

Original source

 

Registration

Register for receiving PharmaAround news, register for PharmAround events.
Continue registration